Swiss National Bank’s Accelerate Diagnostics AXDX Stock Holding History

Swiss National Bank’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,530	Closed	-$123K	–	2746
2022 Q1	$123K	Buy	8,530 +1,360	+19%	+$38.7K	﹤0.01%	2686
2021 Q4	$374K	Hold	7,170	–	–	﹤0.01%	2701
2021 Q3	$418K	Hold	7,170	–	–	﹤0.01%	2598
2021 Q2	$578K	Hold	7,170	–	–	﹤0.01%	2614
2021 Q1	$597K	Buy	7,170 +310	+5%	+$31.4K	﹤0.01%	2441
2020 Q4	$520K	Hold	6,860	–	–	﹤0.01%	2455
2020 Q3	$731K	Hold	6,860	–	–	﹤0.01%	2248
2020 Q2	$1.04M	Buy	6,860 +1,030	+18%	+$102K	﹤0.01%	2076
2020 Q1	$486K	Buy	5,830 +90	+2%	+$12.7K	﹤0.01%	2197
2019 Q4	$970K	Buy	5,740 +190	+3%	+$31.4K	﹤0.01%	2155
2019 Q3	$1.03M	Hold	5,550	–	–	﹤0.01%	2044
2019 Q2	$1.27M	Sell	5,550 -380	-6%	-$74.3K	﹤0.01%	1982
2019 Q1	$1.25M	Buy	5,930 +150	+3%	+$28.1K	﹤0.01%	1952
2018 Q4	$665K	Hold	5,780	–	–	﹤0.01%	2233
2018 Q3	$1.33M	Hold	5,780	–	–	﹤0.01%	1984
2018 Q2	$1.29M	Hold	5,780	–	–	﹤0.01%	2011
2018 Q1	$1.32M	Buy	5,780 +190	+3%	+$49.9K	﹤0.01%	1912
2017 Q4	$1.47M	Hold	5,590	–	–	﹤0.01%	1846
2017 Q3	$1.25M	Hold	5,590	–	–	﹤0.01%	1917
2017 Q2	$1.53M	Buy	5,590 +350	+7%	+$94.9K	﹤0.01%	1761
2017 Q1	$1.27M	Hold	5,240	–	–	﹤0.01%	1861
2016 Q4	$1.09M	Hold	5,240	–	–	﹤0.01%	1978
2016 Q3	$1.43M	Sell	5,240 -170	-3%	-$37.6K	﹤0.01%	1736
2016 Q2	$778K	Buy	5,410 +140	+3%	+$18.8K	﹤0.01%	2110
2016 Q1	$733K	Buy	5,270 +920	+21%	+$130K	﹤0.01%	2091
2015 Q4	$935K	Buy	4,350 +600	+16%	+$110K	﹤0.01%	1868
2015 Q3	$607K	Buy	3,750 +1,140	+44%	+$247K	﹤0.01%	2074
2015 Q2	$674K	Buy	2,610 +100	+4%	+$23.9K	﹤0.01%	2053
2015 Q1	$565K	Hold	2,510	–	–	﹤0.01%	2106
2014 Q4	$482K	Hold	2,510	–	–	﹤0.01%	2202
2014 Q3	$539K	Hold	2,510	–	–	﹤0.01%	2055
2014 Q2	$653K	Buy	+2,510	New	+$548K	﹤0.01%	1989

Other funds holding AXDX

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

CIA

Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAM

Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return

Swiss National Bank's AXDX Position: Q2 2022 in Review

Swiss National Bank sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 8,530 shares — an estimated $123K sold.

Swiss National Bank first reported a position in AXDX in Q2 2014 and held it in 32 quarters. The position peaked at $1.53M in Q2 2017. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

Swiss National Bank reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
Swiss National Bank sold 8,530 Accelerate Diagnostics shares in Q2 2022, an estimated $123K.
Swiss National Bank first reported a position in Accelerate Diagnostics in Q2 2014 and held it in 32 quarters.
Swiss National Bank's Accelerate Diagnostics position peaked at $1.53M in Q2 2017.
74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.